IRIS Accounts Production v24.2.0.383 10114814 Board of Directors Board of Directors 1.3.23 29.2.24 29.2.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101148142023-02-28101148142024-02-29101148142023-03-012024-02-29101148142022-02-28101148142022-03-012023-02-28101148142023-02-2810114814ns15:EnglandWales2023-03-012024-02-2910114814ns14:PoundSterling2023-03-012024-02-2910114814ns10:Director12023-03-012024-02-2910114814ns10:Director22023-03-012024-02-2910114814ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2910114814ns10:SmallEntities2023-03-012024-02-2910114814ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2910114814ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2910114814ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2910114814ns10:AbridgedAccounts2023-03-012024-02-2910114814ns10:EntityNoLongerTradingButTradedInPast2023-03-012024-02-2910114814ns10:OrdinaryShareClass12023-03-012024-02-2910114814ns10:RegisteredOffice2023-03-012024-02-2910114814ns5:CurrentFinancialInstruments2024-02-2910114814ns5:CurrentFinancialInstruments2023-02-2810114814ns5:ShareCapital2024-02-2910114814ns5:ShareCapital2023-02-2810114814ns5:RetainedEarningsAccumulatedLosses2024-02-2910114814ns5:RetainedEarningsAccumulatedLosses2023-02-2810114814ns10:OrdinaryShareClass12024-02-29
REGISTERED NUMBER: 10114814 (England and Wales)















Report of the Directors and


Abridged Cessation Financial Statements for the Year Ended 29 February 2024

for

Above N Beyond Therapies Limited

Above N Beyond Therapies Limited (Registered number: 10114814)






Contents of the Financial Statements
for the Year Ended 29 February 2024




Page

Company Information 1

Report of the Directors 2

Abridged Balance Sheet 3

Notes to the Financial Statements 5


Above N Beyond Therapies Limited

Company Information
for the Year Ended 29 February 2024







DIRECTORS: M McDonald
Mrs A McDonald





REGISTERED OFFICE: Suite 7
Turner Business Centre
Greengate
Middleton
Greater Manchester
M24 1RU





REGISTERED NUMBER: 10114814 (England and Wales)





ACCOUNTANTS: TH Accounting Solutions
Suite 3
Turner Business Centre
Greengate
Middleton
Greater Manchester
M24 1RU

Above N Beyond Therapies Limited (Registered number: 10114814)

Report of the Directors
for the Year Ended 29 February 2024

The directors present their report with the financial statements of the company for the year ended 29 February 2024.

CESSATION OF TRADING
The company ceased trading on 28 February 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 March 2023 to the date of this report.

M McDonald
Mrs A McDonald

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





M McDonald - Director


29 July 2024

Above N Beyond Therapies Limited (Registered number: 10114814)

Abridged Balance Sheet
29 February 2024

29.2.24 28.2.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 153 153

CURRENT ASSETS
Debtors 61,517 61,517
Cash at bank 117 117
61,634 61,634
CREDITORS
Amounts falling due within one year 7,156 7,156
NET CURRENT ASSETS 54,478 54,478
TOTAL ASSETS LESS CURRENT
LIABILITIES

54,631

54,631

CAPITAL AND RESERVES
Called up share capital 5 100 100
Retained earnings 54,531 54,531
SHAREHOLDERS' FUNDS 54,631 54,631

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Above N Beyond Therapies Limited (Registered number: 10114814)

Abridged Balance Sheet - continued
29 February 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 29 February 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 July 2024 and were signed on its behalf by:




M McDonald - Director



Mrs A McDonald - Director


Above N Beyond Therapies Limited (Registered number: 10114814)

Notes to the Financial Statements
for the Year Ended 29 February 2024

1. STATUTORY INFORMATION

Above N Beyond Therapies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2023
and 29 February 2024 363
DEPRECIATION
At 1 March 2023
and 29 February 2024 210
NET BOOK VALUE
At 29 February 2024 153
At 28 February 2023 153

Above N Beyond Therapies Limited (Registered number: 10114814)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 29.2.24 28.2.23
value: £    £   
100 Ordinary 1 100 100